CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Double-Blind, Randomized, Placebo-Controlled Study to Investigate the Safety and Efficacy of STRI Formula in Non-Hospitalized Participants with COVID...
Phase 2
Oak Forest, Illinois, United States and 12 other locations
of the study is to assess the safety and immunogenicity of IIV-HD (high-dose inactivated influenza vaccine) + rC19 (adjuvanted recombinant COVID...
Phase 1, Phase 2
Chicago, Illinois, United States and 11 other locations
vaccine for the prevention of symptomatic Coronavirus Disease 2019 (COVID-19).In order to represent a more recently circulating SAR...
Phase 2
Chicago, Illinois, United States and 144 other locations
seek to enroll immunocompromised patients with Lower Tract parainfluenza infection.It also contains a sub-study to enroll patients with severe COVID...
Phase 3
Chicago, Illinois, United States and 66 other locations
The purpose of the study is to evaluate whether ibuzatrelvir is effective and safe in adults and adolescents with COVID-19 who do n...
Phase 3
Oak Brook, Illinois, United States and 121 other locations
study treatment works in the study) of the study medicine (called nirmatrelvir/ritonavir) for potential treatment of coronavirus disease 2019 (COVID...
Phase 3
Chicago, Illinois, United States and 74 other locations
The purpose of this study is to evaluate the immunogenicity, reactogenicity, and safety, of mRNA-1083 multicomponent influenza and COVID-19...
Phase 2
Melrose Park, Illinois, United States and 16 other locations
the study vaccine (called COMIRNATY) for the potential prevention of COVID-19. This study is seeking participants who:1. Are age \<...
Phase 4
Chicago, Illinois, United States and 31 other locations
side effects. However, it was an expensive treatment and was eventually replaced with less expensive treatment options like penicillin.The COVID...
Phase 2
Maywood, Illinois, United States and 6 other locations
This study will evaluate the safety and immunogenicity of the mRNA-1273.214 vaccine for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)...
Phase 3
Chicago, Illinois, United States and 73 other locations
Clinical trials
Research sites
Resources
Legal